SARS (SEVERE ACUTE RESPIRATORY SYNDROME) – A NEW CHALLENGE FOR THE MANKIND

SARS (SEVERE ACUTE RESPIRATORY SYNDROME) – A NEW CHALLENGE FOR THE MANKIND

Andrej Trampuz, Leopold Rezar, Viktorija Tomič, Igor Muzlovič

Background. SARS (severe acute respiratory syndrome) is a recently recognized new infectious respiratory illness, which first appeared in southern China in November 2002, and has since then within months spread to 29 countries. In total, 8437 cases and 813 deaths occurred (situation as of August 1, 2003). SARS is caused by a novel coronavirus that is primarily spread by large droplet transmission, less commonly by surface contamination or by air (airborne). Around half of the infected were health care workers; the majority of cases acquired the infection in the hospital.Conclusions. Incubation period of SARS is 2 to 10 days. Early manifestations include fever, myalgia, and headache, followed 2 to 4 days later by cough, shortness of breath, and diarrhea. In 10–20% of patients, tracheal intubation and mechanical ventilation is required. Case-fatality is approximately 15%, in patients aged 60 years or older may be higher than 40%. There is no specific therapy or vaccine, and management consists of supportive care. This article summarizes updated information regarding epidemiology, clinical features, etiologic agent, modes of transmission of the disease, and infection control measures to contain SARS.

2003

SARS, severe acute respiratory syndrome, atypical pneumonia, coronavirus

DOI:

Zdravniški Vestnik

Slovenian Medical Association

Medicine

EN, SL